Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

274.45
BATS BZX Real-Time Price
As of 1:21pm ET
 -0.10 / -0.04%
Today’s Change
237.50
Today|||52-Week Range
340.34
-12.18%
Year-to-Date

Today’s Trading

Previous close274.55
Today’s open277.30
Day’s range272.23 - 277.64
Volume1,284,020
Average volume (3 months)4,070,931
Market cap$108.2B
Dividend yield--
Data as of 1:21pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+10.36%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.21+0.55%
BMYBristol-Myers Squibb+0.16+0.27%
NVONovo Nordisk-0.24-0.49%
GSKGlaxoSmithKline+0.40+1.02%
Data as of 1:26pm ET, 02/12/2016

Financials

Next reporting dateFebruary 22, 2016
EPS forecast (this quarter)$3.34
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
President-Generic &
Global Operations, EVP
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers